GlassScriptPhysician profile
Fred Thomas J Lee
NPI 1457593238
$3,386.64
in general payments reported to CMS, 2019-2025
23 companies · $370 in 2025
The $370 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2020: $927 · 2021: $574 · 2022: $381 · 2023: $167 · 2024: $531 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,018 · Education: $50.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,018.09 |
| Education | $50.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Goode Surgical INC | $895.68 | 2020 | |
| Allergan, INC. | $440.93 | 2019-2022 | |
| Tela Bio, INC. | $384.92 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $311.35 | 2023-2025 | |
| Mentor Worldwide LLC | $278.75 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Smith+Nephew, INC. | $194.11 | 2020-2023 | Pico, Oasis |
| Galderma Laboratories, L.P. | $174.07 | 2019 | |
| Avita Medical Americas, LLC | $138.89 | 2024 | |
| Merz North America, INC. | $120.79 | 2019 | |
| Sientra, INC. | $69.89 | 2022 | |
| Acera Surgical, INC. | $69.55 | 2021-2024 | Restrata Wound Matrix |
| Polynovo North America LLC | $67.34 | 2022-2024 | Novosorb Btm |
| Becton, Dickinson and Company | $41.42 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $38.59 | 2024-2025 | |
| Lifenet Health | $28.55 | 2024 | Theragenesis Wound Matrix |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21.27 | 2021 | |
| Heron Therapeutics, INC. | $19.69 | 2025 | Zynrelef |
| Endo Pharmaceuticals INC. | $16.49 | 2020 | |
| Innocoll Pharmaceuticals Limited | $16.28 | 2022 | |
| Integra Lifesciences Corporation | $15.11 | 2024 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Kci USA, INC. | $14.83 | 2023 | Prevena |
| Astrazeneca Pharmaceuticals LP | $14.75 | 2024 | |
| Ethicon US, LLC | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Thomas Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.